Skip to content

Evommune EVMN Allowance For Inventory Obsolescence

Allowance For Inventory Obsolescence at other companies

Mayville Engineering logo
Mayville EngineeringMEC
$106K+165%
Mayville Engineering logo
Mayville EngineeringMEC
$106K+165%
Glaukos logo
GlaukosGKOS
$334.75K+102%
Celsius Holdings, Inc. logo
Celsius Holdings, Inc.CELH
-$1.75M+67.2%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$230.75K+663%
Fox Factory Holding Corp. logo
Fox Factory Holding Corp.FOXF
$512K-70.4%

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+39.5%
Enterprise value$849.52M
P/S127.3×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept meha:AllowanceForInventoryObsolescence.

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's allowance for inventory obsolescence.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's allowance for inventory obsolescence?
Evommune (EVMN) reported allowance for inventory obsolescence of $40.96K in Q4 2025.
How has Evommune 's allowance for inventory obsolescence changed year-over-year?
Evommune 's allowance for inventory obsolescence increased by 1253.3% year-over-year, from -$3.55K to $40.96K.
What does allowance for inventory obsolescence mean?
A valuation reserve established to account for inventory that is no longer expected to be sold or used due to expiration, technological advancement, or market changes. This reflects the risk of asset impairment within the company's supply chain and product portfolio.